The experience of ulipristal acetate using in patients with uterine leiomyoma
In the study of clinical experience of the use of ulipristal acetate (UPA) – a selective modulator of progesterone receptors – in women with symptomatic uterine leiomyoma, 65 women with a clinically significant tumor were treated. The drug was given to patients both as a drug monotherapy, and as a s...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Publishing House TRILIST
2017-09-01
|
| Series: | Репродуктивная эндокринология |
| Subjects: | |
| Online Access: | http://reproduct-endo.com/article/view/110060 |